Review



ska121  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    MedChemExpress ska121
    Effects of K Ca 3.1 activation and LRRC8A inhibition on CCL2 expression and secretion in M 2 -MACs. ( A , B ): Real-time PCR examination of CCL22 ( A ) and CCL2 ( B ) expression in native THP-1 cells (native) and M 2 -MACs (M 2 ) ( n = 4). Data are normalized to ACTB. ( C , D , F , G ): Real-time PCR examination of CCL22 ( C , F ) and CCL2 ( D , G ) expression following treatment with vehicle, 10 μM <t>SKA121</t> (SKA) ( C , D ), or 10 μM endovion (EDV) ( F , G ) for 12 h in M 2 -MACs ( n = 4). Expression levels are normalized to ACTB and shown relative to vehicle control (set as 1.0). ( E , H ): ELISA quantification of CCL2 secretion after 24 h treatment with SKA ( E ) or EDV ( H ) in M 2 -MACs ( n = 4). Secretion levels are shown relative to vehicle control (set as 1.0). **: p < 0.01 vs. native THP-1 or vehicle control.
    Ska121, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ska121/product/MedChemExpress
    Average 93 stars, based on 3 article reviews
    ska121 - by Bioz Stars, 2026-03
    93/100 stars

    Images

    1) Product Images from "Transcriptional Repression of CCL2 by K Ca 3.1 K + Channel Activation and LRRC8A Anion Channel Inhibition in THP-1-Differentiated M 2 Macrophages"

    Article Title: Transcriptional Repression of CCL2 by K Ca 3.1 K + Channel Activation and LRRC8A Anion Channel Inhibition in THP-1-Differentiated M 2 Macrophages

    Journal: International Journal of Molecular Sciences

    doi: 10.3390/ijms26157624

    Effects of K Ca 3.1 activation and LRRC8A inhibition on CCL2 expression and secretion in M 2 -MACs. ( A , B ): Real-time PCR examination of CCL22 ( A ) and CCL2 ( B ) expression in native THP-1 cells (native) and M 2 -MACs (M 2 ) ( n = 4). Data are normalized to ACTB. ( C , D , F , G ): Real-time PCR examination of CCL22 ( C , F ) and CCL2 ( D , G ) expression following treatment with vehicle, 10 μM SKA121 (SKA) ( C , D ), or 10 μM endovion (EDV) ( F , G ) for 12 h in M 2 -MACs ( n = 4). Expression levels are normalized to ACTB and shown relative to vehicle control (set as 1.0). ( E , H ): ELISA quantification of CCL2 secretion after 24 h treatment with SKA ( E ) or EDV ( H ) in M 2 -MACs ( n = 4). Secretion levels are shown relative to vehicle control (set as 1.0). **: p < 0.01 vs. native THP-1 or vehicle control.
    Figure Legend Snippet: Effects of K Ca 3.1 activation and LRRC8A inhibition on CCL2 expression and secretion in M 2 -MACs. ( A , B ): Real-time PCR examination of CCL22 ( A ) and CCL2 ( B ) expression in native THP-1 cells (native) and M 2 -MACs (M 2 ) ( n = 4). Data are normalized to ACTB. ( C , D , F , G ): Real-time PCR examination of CCL22 ( C , F ) and CCL2 ( D , G ) expression following treatment with vehicle, 10 μM SKA121 (SKA) ( C , D ), or 10 μM endovion (EDV) ( F , G ) for 12 h in M 2 -MACs ( n = 4). Expression levels are normalized to ACTB and shown relative to vehicle control (set as 1.0). ( E , H ): ELISA quantification of CCL2 secretion after 24 h treatment with SKA ( E ) or EDV ( H ) in M 2 -MACs ( n = 4). Secretion levels are shown relative to vehicle control (set as 1.0). **: p < 0.01 vs. native THP-1 or vehicle control.

    Techniques Used: Activation Assay, Inhibition, Expressing, Real-time Polymerase Chain Reaction, Control, Enzyme-linked Immunosorbent Assay



    Similar Products

    ska121  (MedChemExpress)
    93
    MedChemExpress ska121
    Effects of K Ca 3.1 activation and LRRC8A inhibition on CCL2 expression and secretion in M 2 -MACs. ( A , B ): Real-time PCR examination of CCL22 ( A ) and CCL2 ( B ) expression in native THP-1 cells (native) and M 2 -MACs (M 2 ) ( n = 4). Data are normalized to ACTB. ( C , D , F , G ): Real-time PCR examination of CCL22 ( C , F ) and CCL2 ( D , G ) expression following treatment with vehicle, 10 μM <t>SKA121</t> (SKA) ( C , D ), or 10 μM endovion (EDV) ( F , G ) for 12 h in M 2 -MACs ( n = 4). Expression levels are normalized to ACTB and shown relative to vehicle control (set as 1.0). ( E , H ): ELISA quantification of CCL2 secretion after 24 h treatment with SKA ( E ) or EDV ( H ) in M 2 -MACs ( n = 4). Secretion levels are shown relative to vehicle control (set as 1.0). **: p < 0.01 vs. native THP-1 or vehicle control.
    Ska121, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ska121/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    ska121 - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    Effects of K Ca 3.1 activation and LRRC8A inhibition on CCL2 expression and secretion in M 2 -MACs. ( A , B ): Real-time PCR examination of CCL22 ( A ) and CCL2 ( B ) expression in native THP-1 cells (native) and M 2 -MACs (M 2 ) ( n = 4). Data are normalized to ACTB. ( C , D , F , G ): Real-time PCR examination of CCL22 ( C , F ) and CCL2 ( D , G ) expression following treatment with vehicle, 10 μM SKA121 (SKA) ( C , D ), or 10 μM endovion (EDV) ( F , G ) for 12 h in M 2 -MACs ( n = 4). Expression levels are normalized to ACTB and shown relative to vehicle control (set as 1.0). ( E , H ): ELISA quantification of CCL2 secretion after 24 h treatment with SKA ( E ) or EDV ( H ) in M 2 -MACs ( n = 4). Secretion levels are shown relative to vehicle control (set as 1.0). **: p < 0.01 vs. native THP-1 or vehicle control.

    Journal: International Journal of Molecular Sciences

    Article Title: Transcriptional Repression of CCL2 by K Ca 3.1 K + Channel Activation and LRRC8A Anion Channel Inhibition in THP-1-Differentiated M 2 Macrophages

    doi: 10.3390/ijms26157624

    Figure Lengend Snippet: Effects of K Ca 3.1 activation and LRRC8A inhibition on CCL2 expression and secretion in M 2 -MACs. ( A , B ): Real-time PCR examination of CCL22 ( A ) and CCL2 ( B ) expression in native THP-1 cells (native) and M 2 -MACs (M 2 ) ( n = 4). Data are normalized to ACTB. ( C , D , F , G ): Real-time PCR examination of CCL22 ( C , F ) and CCL2 ( D , G ) expression following treatment with vehicle, 10 μM SKA121 (SKA) ( C , D ), or 10 μM endovion (EDV) ( F , G ) for 12 h in M 2 -MACs ( n = 4). Expression levels are normalized to ACTB and shown relative to vehicle control (set as 1.0). ( E , H ): ELISA quantification of CCL2 secretion after 24 h treatment with SKA ( E ) or EDV ( H ) in M 2 -MACs ( n = 4). Secretion levels are shown relative to vehicle control (set as 1.0). **: p < 0.01 vs. native THP-1 or vehicle control.

    Article Snippet: EDV (HY-105917), SKA121 (HY-107414), SP600125 (HY-12041), and PD169316 (HY-10578) were from MedChemExpress (Monmouth Junction, NJ, USA).

    Techniques: Activation Assay, Inhibition, Expressing, Real-time Polymerase Chain Reaction, Control, Enzyme-linked Immunosorbent Assay